Biotechnology AstraZeneca Says Lynparza/Imfinzi Combo Shows Strong Clinical Benefit Vs. Chemotherapy In Endometrial Cancer – AstraZeneca (NASDAQ:AZN) Read more
Biotechnology Investors Cheer Acelyrin’s Stock, Its Second Lead Candidate Shows Clinical Benefit In Thyroid Eye Disease Patients – Acelyrin (NASDAQ:SLRN) Read more
Biotechnology First Wave BioPharma Announces Completion of Business Combination with ImmunogenX, Adding Phase 3-Ready Latiglutenase to its Late-Stage GI-Focused Clinical Pipeline – First Wave BioPharma (NASDAQ:FWBI) Read more
Biotechnology Ocugen, Inc. Announces Dosing Completion of Subjects with Geographic Atrophy in Cohort 1 of Phase 1/2 Clinical Trial Evaluating the Safety and Efficacy of OCU410 – Ocugen (NASDAQ:OCGN) Read more
Stockmarkets Phio Pharmaceuticals expands clinical trial sites for cancer study By biedexmarkets.com Read more
Biotechnology FDA Grants Cybin Breakthrough Therapy Status For Major Depression Psilocybin Therapy, Company Announces Positive Clinical Data & Canadian $150M Private Placement – Compass Pathways (NASDAQ:CMPS), Cybin (AMEX:CYBN) Read more
Biotechnology Skin Disease-Focused AnaptysBio Earns Analyst Upgrade On Positive Outlook For Clinical Triggers – AnaptysBio (NASDAQ:ANAB) Read more
Biotechnology Psyence Biomedical Will Undertake Psilocybin Clinical Trials For Palliative Care In Australia – Psyence Biomedical (NASDAQ:PBM) Read more
Biotechnology MindMeds Systematic Biotech Approach With New FDA Therapy Designation, 12-Week Clinical Data, Plus Expected $175M Proceeds – Mind Medicine (NASDAQ:MNMD) Read more
Biotechnology Athira Pharma Presents Clinical and Preclinical Data Supporting Therapeutic Potential of Fosgonimeton in Alzheimer’s and Parkinson’s Diseases at AD/PD 2024 International Conference – Athira Pharma (NASDAQ:ATHA) Read more